MT-RNR1 Gene Deafness Nonsyndromic Sensorineural Mitochondrial Genetic Test
Components: MT-RNR1 Gene Deafness Nonsyndromic Sensorineural Mitochondrial Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Ear Nose Throat Disorders
Doctor: ENT Doctor
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test gene CATSPER13
Test Details: MT-RNR1 gene deafness, nonsyndromic, sensorineural, mitochondrial NGS genetic test is a genetic test that analyzes the MT-RNR1 gene for mutations associated with nonsyndromic sensorineural deafness. Nonsyndromic deafness refers to hearing loss that occurs without any other associated medical conditions or symptoms. Sensorineural deafness specifically refers to hearing loss caused by problems with the inner ear or the auditory nerve pathways. The MT-RNR1 gene, also known as the mitochondrial 12S rRNA gene, is located in the mitochondria, the energy-producing structures within cells. Mutations in this gene have been linked to sensorineural deafness. NGS (Next-Generation Sequencing) technology is used to analyze the MT-RNR1 gene for any genetic variations or mutations. This technique allows for the simultaneous analysis of multiple genes, providing a comprehensive assessment of genetic changes associated with deafness. By identifying mutations in the MT-RNR1 gene, this genetic test can help diagnose the genetic cause of nonsyndromic sensorineural deafness and provide valuable information for genetic counseling and potential treatment options.
Test Name | MT-RNR1 Gene Deafness nonsyndromic sensorineural mitochondrial Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Ear Nose Throat Disorders |
Doctor | ENT Doctor |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test gene CATSPER13 |
Test Details |
MT-RNR1 gene deafness, nonsyndromic, sensorineural, mitochondrial NGS genetic test is a genetic test that analyzes the MT-RNR1 gene for mutations associated with nonsyndromic sensorineural deafness. Nonsyndromic deafness refers to hearing loss that occurs without any other associated medical conditions or symptoms. Sensorineural deafness specifically refers to hearing loss caused by problems with the inner ear or the auditory nerve pathways. The MT-RNR1 gene, also known as the mitochondrial 12S rRNA gene, is located in the mitochondria, the energy-producing structures within cells. Mutations in this gene have been linked to sensorineural deafness. NGS (Next-Generation Sequencing) technology is used to analyze the MT-RNR1 gene for any genetic variations or mutations. This technique allows for the simultaneous analysis of multiple genes, providing a comprehensive assessment of genetic changes associated with deafness. By identifying mutations in the MT-RNR1 gene, this genetic test can help diagnose the genetic cause of nonsyndromic sensorineural deafness and provide valuable information for genetic counseling and potential treatment options. |